Cell Communication and Signaling,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: April 23, 2022
Abstract
Background
Microglia-mediated
neuroinflammatory
response
following
traumatic
brain
injury
(TBI)
is
considered
as
a
vital
secondary
factor,
which
drives
trauma-induced
neurodegeneration
and
lack
of
efficient
treatment.
ACT001,
sesquiterpene
lactone
derivative,
reportedly
involved
in
alleviation
inflammatory
response.
However,
little
known
regarding
its
function
regulating
innate
immune
central
nervous
system
(CNS)
after
TBI.
This
study
aimed
to
investigate
the
role
underlying
mechanism
ACT001
Methods
Controlled
cortical
impact
(CCI)
models
were
used
establish
model
Cresyl
violet
staining,
evans
blue
extravasation,
neurobehavioral
assessments,
immunofluorescence
transmission
electron
microscopy
evaluate
therapeutic
effects
vivo.
Microglial
depletion
was
induced
by
administering
mice
with
colony
stimulating
factor
1
receptor
(CSF1R)
inhibitor,
PLX5622.
Cell-cell
interaction
established
co-culture
simulate
TBI
conditions
vitro.
Cytotoxic
effect
on
cell
viability
assessed
counting
kit-8
activation
microglia
cells
Lipopolysaccharides
(LPS).
Pro-inflammatory
cytokines
expression
determined
Real-time
PCR
nitric
oxide
production.
Apoptotic
detected
TUNEL
flow
cytometry
assays.
Tube
formation
performed
cellular
angiogenic
ability.
ELISA
western
blot
experiments
determine
proteins
expression.
Pull-down
assay
analyze
that
bound
ACT001.
Results
relieved
extent
blood-brain
barrier
integrity
damage
alleviated
motor
deficits
via
reducing
cells.
Delayed
PLX5622
hindered
Furthermore,
LPS-induced
mouse
rat
primary
Besides,
effective
suppressing
pro-inflammatory
production
BV2
cells,
resulting
reduction
neuronal
apoptosis
HT22
improvement
tube
bEnd.3
Mechanism
functioned
related
AKT/NFκB/NLRP3
pathway.
restrained
NFκB
nuclear
translocation
through
inhibiting
AKT
phosphorylation,
decrease
NLRP3
inflammasome
activation,
finally
down-regulated
microglial
Conclusions
Our
indicated
played
critical
microglia-mediated
might
be
novel
potential
chemotherapeutic
drug
for
Chinese Journal of Traumatology,
Journal Year:
2018,
Volume and Issue:
21(3), P. 137 - 151
Published: April 24, 2018
Traumatic
brain
injury
(TBI)
remains
a
major
cause
of
death
and
disability
worldwide.
Increasing
evidence
indicates
that
TBI
is
an
important
risk
factor
for
neurodegenerative
diseases
including
Alzheimer's
disease,
Parkinson's
chronic
traumatic
encephalopathy.
Despite
improved
supportive
rehabilitative
care
patients,
unfortunately,
all
late
phase
clinical
trials
in
have
yet
to
yield
safe
effective
neuroprotective
treatment.
The
disappointing
may
be
attributed
variability
treatment
approaches
heterogeneity
the
population
patients
as
well
race
against
time
prevent
or
reduce
inexorable
cell
death.
not
just
acute
event
but
disease.
Among
many
mechanisms
involved
secondary
after
TBI,
emerging
preclinical
studies
indicate
posttraumatic
prolonged
progressive
neuroinflammation
associated
with
neurodegeneration
which
treatable
long
initiating
injury.
This
review
provides
overview
recent
understanding
cell-based
therapies
target
promote
functional
recovery
TBI.
Brain Injury,
Journal Year:
2017,
Volume and Issue:
31(9), P. 1195 - 1203
Published: July 29, 2017
The
purpose
of
this
paper
is
to
review
the
clinical
and
research
utility
applications
blood,
cerebrospinal
fluid
(CSF),
cerebral
microdialysis
biomarkers
in
traumatic
brain
injury
(TBI).Not
applicable.A
selective
was
performed
on
these
biofluid
TBI.Neurofilament
heavy
chain
protein
(NF-H),
glial
fibrillary
acidic
(GFAP),
ubiquitin
C-terminal
hydrolase-L1
(UCHL1),
neuron-specific
enolase
(NSE),
myelin
basic
(MBP),
tau,
s100β
blood
are
elevated
during
acute
phase
severe
head
trauma
but
have
key
limitations
their
mild
TBI
(mTBI).
CSF
currently
provide
best
reflection
central
nervous
system
(CNS)
pathobiological
processes
TBI.
Both
animal
human
studies
demonstrated
importance
serial
sampling
biofluids
suggest
that
may
be
better
equipped
characterize
both
severity
temporal
profiles.The
identification
could
play
a
vital
role
identifying,
diagnosing,
treating
underlying
individual
changes
CNS-derived
exosomes
analyzed
by
ultra-high
sensitivity
detection
methods
potential
identify
for
range
time
course.
Journal of Neuroinflammation,
Journal Year:
2020,
Volume and Issue:
17(1)
Published: April 6, 2020
There
is
a
great
clinical
need
to
identify
the
underlying
mechanisms,
as
well
related
biomarkers,
and
treatment
targets,
for
traumatic
brain
injury
(TBI).
Neuroinflammation
central
pathophysiological
feature
of
TBI.
NLRP3
inflammasome
activity
necessary
component
innate
immune
response
tissue
damage,
dysregulated
has
been
implicated
in
number
neurological
conditions.
This
paper
introduces
its
implication
pathogenesis
neuroinflammatory-related
conditions,
with
particular
focus
on
Although
role
TBI
only
recently
identified,
findings
suggest
that
priming
activation
are
upregulated
following
Moreover,
recent
studies
utilizing
specific
inhibitors
have
provided
further
evidence
this
major
driver
neuroinflammation
neurobehavioral
disturbances
In
addition,
there
emerging
circulating
inflammasome-associated
proteins
may
utility
diagnostic
biomarkers
neuroinflammatory
including
Finally,
novel
promising
areas
research
will
be
highlighted,
potential
involvement
mild
TBI,
how
factors
such
biological
sex
affect
use
biomarker
platforms.
Taken
together,
review
highlights
exciting
target
treatments
ultimately
used
improve
management.
Brain,
Journal Year:
2020,
Volume and Issue:
144(1), P. 18 - 31
Published: Sept. 10, 2020
Traumatic
brain
injury
(TBI)
is
a
leading
cause
of
death
and
disability
worldwide
risk
factor
for
dementia
later
in
life.
Research
into
the
pathophysiology
TBI
has
focused
on
impact
neuron.
However,
recent
advances
have
shown
that
major
synapse
structure
function
through
combination
immediate
mechanical
insult
ensuing
secondary
processes,
to
loss.
In
this
review,
we
highlight
role
with
focus
confluence
multiple
processes
including
excitotoxicity,
inflammation
oxidative
stress.
The
primary
triggers
cascade
events
each
these
discuss
complex
interplay
occurs
at
synapse.
We
also
examine
how
impacted
by
traumatic
axonal
it
may
play
spread
tau
after
TBI.
propose
astrocytes
crucial
mediating
both
loss
recovery.
Finally,
developments
field
molecular
imaging,
fluid
biomarkers
therapeutics.
particular,
our
understanding
diversity
suggest
new
technology
synaptome
mapping
prove
useful
identifying
synapses
are
vulnerable
or
resistant
Journal of Advanced Research,
Journal Year:
2020,
Volume and Issue:
28, P. 97 - 109
Published: Aug. 18, 2020
Currently,
spinal
cord
injury
(SCI)
is
a
pathological
incident
that
triggers
several
neuropathological
conditions,
leading
to
the
initiation
of
neuronal
damage
with
pro-inflammatory
mediators'
release.
However,
pyroptosis
recognized
as
new
programmed
cell
death
mechanism
regulated
by
stimulation
caspase-1
and/or
caspase-11/-4/-5
signaling
pathways
series
inflammatory
responses.
Our
current
review
concisely
summarizes
potential
role
pyroptosis-regulated
in
SCI,
according
molecular
and
pathophysiological
mechanisms.
This
also
highlights
targeting
inflammasome
components
its
therapeutic
implications
for
treatment
SCI.
Multiple
pieces
evidence
have
illustrated
plays
significant
roles
swelling,
plasma
membrane
lysis,
chromatin
fragmentation
intracellular
factors
including
IL-18
IL-1β
In
addition,
directly
mediated
recently
discovered
family
pore-forming
protein
known
GSDMD.
Current
investigations
documented
critical
pathogenesis
multiple
neurological
disorders
well
narrative
article
suggests
inhibiting
could
be
promising
approach
SCI
near
future.
Journal of Neuroinflammation,
Journal Year:
2019,
Volume and Issue:
16(1)
Published: April 11, 2019
Neuroinflammation
is
an
essential
player
in
many
neurological
diseases
including
traumatic
brain
injury
(TBI).
Recent
studies
have
identified
that
inflammasome
complexes
are
responsible
for
inflammatory
responses
pathological
conditions.
Inflammasomes
intracellular
multiprotein
which
regulate
the
innate
immune
response,
activation
of
caspase-1,
production
pro-inflammatory
cytokines
IL-1β
and
IL-18,
induction
cell
death
(pyroptosis).
Among
family
members,
nucleotide-binding
domain
leucine-rich
repeats
protein
3
(NLRP3)
most
extensively
studied
its
induced
following
TBI.
As
a
novel
target,
drug
development
targeting
formation
NLRP3
prospective
therapy
We
recently
developed
small
molecule
JC124
with
specificity
on
inflammasome.
In
this
study,
we
explored
therapeutic
value
TBI
treatment.
Adult
male
Sprague-Dawley
rats
were
subjected
to
moderate
cortical
impact
injury.
Following
TBI,
animals
received
4
doses
treatment
first
dose
starting
at
30
min,
second
6
h
after
third
fourth
24
or
respectively.
Animals
sacrificed
2
days
post-injury.
Brain
tissues
processed
either
ELISA
western
blotting
analysis
histological
examination
assess
degenerative
neurons,
acute
response
lesion
volume.
found
post-injury
significantly
decreased
number
injury-induced
degenerating
injured
brain,
Injured
treated
also
had
reduced
expression
levels
NLRP3,
ASC,
IL-1
beta,
TNFα,
iNOS,
caspase-1.
Our
data
suggest
our
inhibitor
has
specific
anti-inflammatory
effect
protect
Journal of Neuroinflammation,
Journal Year:
2020,
Volume and Issue:
17(1)
Published: June 15, 2020
Abstract
Background
Aucubin
(Au),
an
iridoid
glycoside
from
natural
plants,
has
antioxidative
and
anti-inflammatory
bioactivities;
however,
its
effects
on
a
traumatic
brain
injury
(TBI)
model
remain
unknown.
We
explored
the
potential
role
of
Au
in
H
2
O
-induced
oxidant
damage
primary
cortical
neurons
weight-drop
induced-TBI
mouse
model.
Methods
In
vitro
experiments,
various
concentrations
(50
μg/ml,
100
or
200
μg/ml)
were
added
culture
medium
at
0
h
6
after
stimulated
by
(100
μM).
After
exposed
for
12
h,
collected
western
blot
(WB),
immunofluorescence,
M29,79-dichlorodihydrofluorescein
diacetate
(DCFH-DA)
staining.
vivo
(20
mg/kg
40
mg/kg)
was
administrated
intraperitoneally
30
min,
24
48
modeling.
Brain
water
content,
neurological
deficits,
cognitive
functions
measured
specific
time,
respectively.
Cortical
tissue
around
focal
trauma
WB,
TdT-mediated
dUTP
Nick-End
Labeling
(TUNEL)
staining,
Nissl
quantitative
real
time
polymerase
chain
reaction
(q-PCR),
immunofluorescence/immunohistochemistry,
enzyme
linked
immunosorbent
assay
(ELISA)
72
TBI.
RNA
interference
experiments
performed
to
determine
nuclear
factor
erythroid-2
related
(Nrf2)
TBI
mice
with
(40
treatment.
Mice
intracerebroventricularly
lentivirus
before
establishment.
The
cortex
obtained
used
WB
q-PCR.
Results
enhanced
translocation
Nrf2
into
nucleus,
activated
antioxidant
enzymes,
suppressed
excessive
generation
reactive
oxygen
species
(ROS),
reduced
cell
apoptosis
both
experiments.
TBI,
markedly
attenuated
edema,
histological
damages,
improved
deficits.
significantly
high
mobility
group
box
1
(HMGB1)-mediated
aseptic
inflammation.
knockdown
blunted
neuroprotective
Au.
Conclusions
Taken
together,
our
data
suggest
that
provides
effect
inhibiting
oxidative
stress
inflammatory
responses;
mechanisms
involve
triggering
Nrf2-induced
system.
Nano Letters,
Journal Year:
2019,
Volume and Issue:
19(7), P. 4527 - 4534
Published: June 18, 2019
Reactive
oxygen
and
nitrogen
species
(RONS),
especially
reactive
(RNS)
are
intermediate
products
during
incidence
of
nervous
system
diseases,
showing
continuous
damage
for
traumatic
brain
injury
(TBI).
Here,
we
developed
a
carbogenic
nanozyme,
which
shows
an
antioxidant
activity
12
times
higher
than
ascorbic
acid
(AA)
behaves
as
multienzyme
mimetics.
Importantly,
the
nanozyme
exhibits
ultrahigh
scavenging
efficiency
(∼16
AA)
toward
highly
active
RNS,
such
•NO
ONOO–
well
traditional
(ROS)
including
O2•–,
H2O2,
•OH.
In
vitro
experiments
show
that
neuron
cells
injured
by
H2O2
or
lipopolysaccharide
can
be
significantly
recovered
after
treatment
via
all
kinds
RONS.
Moreover,
serve
various
enzyme
mimetics
eliminate
harmful
peroxide
glutathione
disulfide
from
mice,
demonstrating
its
potential
therapeutic
acute
TBI.